Rep. Culver’s “Right to Try” legislation signed into law
STATEHOUSE – State Representative Wes Culver (R-Goshen) authored legislation that would allow terminally ill patients to try a drug or treatment that has gone through the first stage of approval for use. House Enrolled Act (HEA) 1065 was signed into law by Governor Pence.
Legislation typically goes into effect July 1st the year they are passed, but HEA 1065 was an emergency act and went into effect immediately upon passage.
“I am proud to be a part of legislation that will benefit so many Hoosiers in need,” said Rep. Culver. “Everyone deserves the right to try potentially life-saving treatment options and HEA 1065 opens that door.”
HEA 1065 would allow patients under certain conditions to try experimental drugs, biological products or devices if they do not have a comparable or satisfactory treatment option. Under this bill, patients would qualify for experimental treatments if they are diagnosed with a terminal illness and the treatment option does not have a probable risk that is greater than the condition. However, a patient would still need to receive physician approval first.
“My goal with this legislation is to increase opportunities for all Hoosiers in their fight for life,” said Rep. Culver. “I look forward to seeing the benefits this law will have for patients across Indiana.”
Present at the bill signing was Jordan McLinn who suffers from a terminal illness and may benefit from this law. For more information on HEA 1065, please visit iga.in.gov.
State Rep. Wes Culver serves as Chairman of the Statutory Committee on Interstate and International Cooperation. He also serves as a member of the Commerce, Small Business and Economic Development; Financial Institutions; and the Select Committee on Government Reduction. Rep. Culver represents a portion of Elkhart County.